title: Vemurafenib-induced cardiac tamponade: a rare but potentially life-threatening complication.
authors.affiliation: Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215, USA. kmmah5@bidmc.harvard.edu
authors.forename: Kathleen M
authors.initials: KM
authors.lastname: Mahoney
authors.forename: Allison
authors.initials: A
authors.lastname: Ackerman
authors.forename: Daniel C
authors.initials: DC
authors.lastname: Cho
authors.forename: David F
authors.initials: DF
authors.lastname: McDermott
authors.forename: Toni
authors.initials: T
authors.lastname: Peters
authors.forename: Michael B
authors.initials: MB
authors.lastname: Atkins
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002305:Cardiac Tamponade / Q000139:chemically induced*; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D008875:Middle Aged; D011379:Prognosis; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib